Robert W. Baird Increases Xylem (NYSE:XYL) Price Target to $155.00

Xylem (NYSE:XYL) had its target price increased by equities research analysts at Robert W. Baird from $151.00 to $155.00 in a report released on Friday, Benzinga reports. The firm presently has an “outperform” rating on the industrial products company’s stock. Robert W. Baird’s price target points to a potential upside of 12.97% from the company’s previous close.

Several other equities analysts have also recently commented on the stock. BNP Paribas began coverage on shares of Xylem in a research note on Tuesday, March 12th. They set an “outperform” rating and a $150.00 target price on the stock. Citigroup lifted their price objective on shares of Xylem from $126.00 to $139.00 and gave the stock a “neutral” rating in a research note on Monday, April 8th. Oppenheimer lifted their price objective on shares of Xylem from $133.00 to $142.00 and gave the stock an “outperform” rating in a research note on Thursday, April 18th. Stifel Nicolaus lifted their price objective on shares of Xylem from $136.00 to $150.00 and gave the stock a “buy” rating in a research note on Wednesday, February 7th. Finally, Raymond James raised shares of Xylem from an “underperform” rating to a “market perform” rating in a research note on Thursday, January 4th. Five investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $140.70.

Xylem Trading Up 0.9 %

Shares of NYSE:XYL opened at $137.21 on Friday. The company has a market cap of $33.26 billion, a PE ratio of 48.83, a P/E/G ratio of 2.67 and a beta of 1.08. The company’s 50-day moving average price is $128.64 and its 200 day moving average price is $115.36. Xylem has a fifty-two week low of $87.59 and a fifty-two week high of $138.46. The company has a quick ratio of 1.30, a current ratio of 1.67 and a debt-to-equity ratio of 0.19.

Xylem (NYSE:XYL) last issued its quarterly earnings data on Thursday, May 2nd. The industrial products company reported $0.90 earnings per share for the quarter, beating the consensus estimate of $0.84 by $0.06. The firm had revenue of $2.03 billion for the quarter, compared to the consensus estimate of $2 billion. Xylem had a net margin of 8.34% and a return on equity of 8.95%. Xylem’s quarterly revenue was up 40.4% compared to the same quarter last year. During the same period last year, the firm posted $0.72 EPS. Sell-side analysts anticipate that Xylem will post 4.2 earnings per share for the current year.

Insider Buying and Selling

In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $122.89, for a total transaction of $122,890.00. Following the completion of the sale, the chief accounting officer now directly owns 2,935 shares in the company, valued at $360,682.15. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the business’s stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $122.89, for a total value of $122,890.00. Following the completion of the sale, the chief accounting officer now directly owns 2,935 shares of the company’s stock, valued at $360,682.15. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Franz Cerwinka sold 2,408 shares of the business’s stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an average price of $121.79, for a total transaction of $293,270.32. Following the completion of the sale, the senior vice president now directly owns 11,750 shares of the company’s stock, valued at $1,431,032.50. The disclosure for this sale can be found here. 0.27% of the stock is currently owned by corporate insiders.

Institutional Trading of Xylem

Large investors have recently added to or reduced their stakes in the business. Bruce G. Allen Investments LLC bought a new stake in shares of Xylem during the 4th quarter worth $27,000. NBC Securities Inc. bought a new stake in shares of Xylem during the 3rd quarter worth $38,000. FinTrust Capital Advisors LLC boosted its holdings in shares of Xylem by 170.9% during the 1st quarter. FinTrust Capital Advisors LLC now owns 317 shares of the industrial products company’s stock worth $41,000 after buying an additional 200 shares during the period. Hazlett Burt & Watson Inc. boosted its holdings in shares of Xylem by 184.9% during the 1st quarter. Hazlett Burt & Watson Inc. now owns 339 shares of the industrial products company’s stock worth $43,000 after buying an additional 220 shares during the period. Finally, Orion Capital Management LLC bought a new stake in shares of Xylem during the 3rd quarter worth $48,000. 87.96% of the stock is owned by institutional investors.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.